Skip to content

Clinical study on prevention and treatment of radiation-induced lung injury with traditional Chinese medicine

Clinical study on prevention and treatment of radiation-induced lung injury with traditional Chinese medicine

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200063252
Enrollment
Unknown
Registered
2022-09-02
Start date
2022-09-01
Completion date
Unknown
Last updated
2023-04-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Radiation induced lung injury

Interventions

experience group:Concurrent radiotherapy and chemotherapy + traditional Chinese medicine

Sponsors

Sichuan Cancer Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Patients with stage II and III (International Association for the study of Lung Cancer TNM 8th Edition) who are confirmed by histopathology or cell pathology to have lung cancer and other chest tumors that are not suitable for surgery are pre treated with radical radiotherapy; 2. It has the indication of concurrent radiotherapy and chemotherapy, and it is the first time to receive radiotherapy, and has not received chemotherapy and surgery; 3. Karnofsky performance status (KPS) score >= 60 points; 4. No obvious chronic lung inflammation was confirmed by lung CT before radiotherapy; 5. Normal blood routine and liver and kidney functions; 6. Aged 18-70 years; 7. Sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Any antineoplastic drugs other than systemic antineoplastic therapy that the subjects have been stably used and any treatment that may have an effect on the control of pulmonary fibrosis; 2. The patient has suffered from severe lung disease and is unlikely to benefit from treatment; 3. Combined with clinically unstable or uncontrollable blood, cardiovascular, lung, liver, kidney, pancreas or endocrine diseases, infectious diseases and mental diseases; 4. In the process of this study, it has been planned to participate in another clinical study of experimental drugs or equipment; 5. Known or suspected allergy to any component of the self-made "chemical fiber soup"; 6. The researcher believes that the subjects are not suitable to participate in this clinical study due to any clinical or laboratory abnormalities or other reasons.

Design outcomes

Primary

MeasureTime frame
Incidence of radiation-induced lung injury;Severity of radiation-induced lung injury;

Countries

China

Contacts

Public ContactYin Jun
31834681@qq.com+86 18380171272

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026